Latest IR information
IR News
- 2026.02.17
- Announcement of FY2025 Grant Award for Research and Development of Orphan Drug for IV BCV for Adenovirus Infection Following Hematopoietic Stem Cell Transplantation
- 2026.02.17
- 株主通信「SymBio VISION vol.28」(Japanese only)
- 2026.02.09
- IV Brincidofovir Phase 2 Clinical Trial Results in CMV Infection Following Hematopoietic Stem Cell Transplantation Presented Orally at the Tandem Meetings
- 2026.02.05
- Summary of Financial Statements for the Fiscal Year Ended December 31, 2025 [Japanese GAAP] (Consolidated)
- 2026.02.02
- Notice Regarding the Monthly Exercise Status of the 58th and 65th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment